Preclinical development of a bridging therapy for radiation casualties

Experimental Hematology

Volumn 38, Issue 1, 2010, Pages 61-70

  Singh, Vijay K ^a,b   Brown, Darren S ^a   Kao, Tzu Cheg ^b   Seed, Thomas M ^c  

^a ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^c Tech Micro Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COBALT 60; GRANULOCYTE COLONY STIMULATING FACTOR; PLERIXAFOR; TOCOPHEROL DERIVATIVE; TOCOPHEROL SUCCINATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION; CONTROLLED STUDY; DRUG SCREENING; GAMMA RADIATION; HEMATOPOIETIC STEM CELL; IMMUNE SYSTEM; IN VITRO STUDY; IONIZING RADIATION; MOUSE; MOUSE STRAIN; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA TRANSFUSION; PRIORITY JOURNAL; PROBABILITY; QUANTITATIVE ANALYSIS; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INJURY; SEPSIS; STEM CELL MOBILIZATION; SURVIVAL; TERRORISM; TISSUE REPAIR; VICTIM; WHOLE BODY RADIATION;

ANIMALS; DISEASE MODELS, ANIMAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MICE; RADIATION INJURIES, EXPERIMENTAL;

MUS;

EID: 71249088476     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2009.10.008     Document Type: Article

References (45)

1. Benjamin G.C., McGeary M., and McCutchen S.R. Assessing medical preparedness to respond to a terrorist nuclear event: workshop report (2009), The National Academies Press, Washington, DC
2. Singh V.K., and Seed T.M. Radiation Effects. In: Roy M.J. (Ed). Physician's guide to terrorist attack (2003), Humana Press, Totowa 339-362
3. Koenig K.L., Goans R.E., Hatchett R.J., et al. Medical treatment of radiological casualties: current concepts. Ann Emerg Med 45 (2005) 643-652
4. Meineke V., van Beuningen D., Sohns T., and Fliedner T.M. Medical management principles for radiation accidents. Mil Med 168 (2003) 219-222
5. Dainiak N., Waselenko J.K., Armitage J.O., MacVittie T.J., and Farese A.M. The hematologist and radiation casualties. Hematology Am Soc Hematol Educ Program (2003) 473-496
6. Seed T.M. Radiation protectants: current status and future prospects. Health Phys 89 (2005) 531-545
7. Pellmar T.C., and Rockwell S. Priority list of research areas for radiological nuclear threat countermeasures. Radiat Res 163 (2005) 115-123
8. Augustine A.D., Gondre-Lewis T., McBride W., Miller L., Pellmar T.C., and Rockwell S. Animal models for radiation injury, protection and therapy. Radiat Res 164 (2005) 100-109
9. Hosseinimehr S.J. Trends in the development of radioprotective agents. Drug Discov Today 12 (2007) 794-805
10. Ghosh S.P., Kulkarni S., Hieber K., et al. Gamma-tocotrienol, a tocol antioxidant as a potent radioprotector. Int J Radiat Biol 85 (2009) 598-606
11. Landauer M.R., Srinivasan V., and Seed T.M. Genistein treatment protects mice from ionizing radiation injury. J Appl Toxicol 23 (2003) 379-385
12. Whitnall M.H., Elliott T.B., Harding R.A., et al. Androstenediol stimulates myelopoiesis and enhances resistance to infection in gamma-irradiated mice. Int J Immunopharmacol 22 (2000) 1-14
13. Burdelya L.G., Krivokrysenko V.I., Tallant T.C., et al. An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science 320 (2008) 226-230
14. Srinivasan V., Doctrow S., Singh V.K., and Whitnall M.H. Evaluation of EUK-189, a synthetic superoxide dismutase/catalase mimetic as a radiation countermeasure. Immunopharmacol Immunotoxicol 30 (2008) 271-290
15. DiCarlo A.L., Hatchett R.J., Kaminski J.M., et al. Medical countermeasures for radiation combined injury: radiation with burn, blast, trauma and/or sepsis. report of an NIAID Workshop, March 26-27, 2007. Radiat Res 169 (2008) 712-721
16. Weiss J.F., and Landauer M.R. History and development of radiation-protective agents. Int J Radiat Biol 85 (2009) 539-573
17. Xiao M., and Whitnall M.H. Pharmacological countermeasures for the acute radiation syndrome. Curr Mol Pharmacol 2 (2009) 122-133
18. Herodin F., Grenier N., and Drouet M. Revisiting therapeutic strategies in radiation casualties. Exp Hematol 35 (2007) 28-33
19. Herodin F., and Drouet M. Myeloprotection following cytotoxic damage: the sooner the better. Exp Hematol 36 (2008) 769-770 Author reply 771-762
20. Herodin F., Mayol J.F., Mourcin F., and Drouet M. Which place for stem cell therapy in the treatment of acute radiation syndrome?. Folia Histochem Cytobiol 43 (2005) 223-227
21. Constantinou C., Papas A., and Constantinou A.I. Vitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs. Int J Cancer 123 (2008) 739-752
22. Zhao Y., Neuzil J., and Wu K. Vitamin E analogues as mitochondria-targeting compounds: from the bench to the bedside?. Mol Nutr Food Res 53 (2009) 129-139
23. Singh V.K., and Brown D.S. T.C.K. Tocopherol succinate: a promising radiation countermeasure. Int Immunopharmacol 9 (2009) 1423-1430
24. Singh V.K., Shafran R.L., Jackson III W.E., Seed T.M., and Kumar K.S. Induction of cytokines by radioprotective tocopherol analogs. Exp Mol Pathol 81 (2006) 55-61
25. Ross J., and Li L. HSC mobilization: new incites and insights. Blood 114 (2009) 1283-1284
26. Flomenberg N., Devine S.M., Dipersio J.F., et al. The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood 106 (2005) 1867-1874
27. Pulliam A.C., Hobson M.J., Ciccone S.L., et al. AMD3100 synergizes with G-CSF to mobilize repopulating stem cells in Fanconi anemia knockout mice. Exp Hematol 36 (2008) 1084-1090
28. Broxmeyer H.E., Orschell C.M., Clapp D.W., et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 201 (2005) 1307-1318
29. Ramirez P., Rettig M.P., Uy G.L., et al. BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells. Blood 114 (2009) 1340-1343
30. Grande T., and Bueren J.A. The mobilization of hematopoietic progenitors to peripheral blood is predictive of the hematopoietic syndrome after total or partial body irradiation of mice. Int J Radiat Oncol Biol Phys 64 (2006) 612-618
31. Mehrotra S., Mishra K.P., Maurya R., Srimal R.C., and Singh V.K. Immunomodulation by ethanolic extract of Boerhaavia diffusa roots. Int Immunopharmacol 2 (2002) 987-996
32. Herodin F., and Drouet M. Cytokine-based treatment of accidentally irradiated victims and new approaches. Exp Hematol 33 (2005) 1071-1080
33. Herodin F., Bourin P., Mayol J.F., Lataillade J.J., and Drouet M. Short-term injection of antiapoptotic cytokine combinations soon after lethal gamma -irradiation promotes survival. Blood 101 (2003) 2609-2616
34. Drouet M., Mathieu J., Grenier N., Multon E., Sotto J.J., and Herodin F. The reduction of in vitro radiation-induced Fas-related apoptosis in CD34+ progenitor cells by SCF, FLT-3 ligand, TPO, and IL-3 in combination resulted in CD34+ cell proliferation and differentiation. Stem Cells 17 (1999) 273-285
35. Drouet M., Mourcin F., Grenier N., et al. [The effects of ionizing radiation on stem cells and hematopoietic progenitors: the place of apoptosis and the therapeutic potential of anti-apoptosis treatments]. Can J Physiol Pharmacol 80 (2002) 700-709
36. Weaver C.H., Schulman K.A., and Buckner C.D. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim. Bone Marrow Transplant 27 Suppl 2 (2001) S23-S29
37. Khoury H., Adkins D., Brown R., et al. Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 25 (2000) 1197-1201
38. Paydas S., Sahin B., Seyrek E., et al. Sweet's syndrome associated with G-CSF. Br J Haematol 85 (1993) 191-192
39. Singh V.K., Shafran R.L., Inal C.E., Jackson III W.E., and Whitnall M.H. Effects of whole-body gamma irradiation and 5-androstenediol administration on serum G-CSF. Immunopharmacol Immunotoxicol 27 (2005) 521-534
40. Singh V.K., Jacobsen K.O., Grace M.B., et al. Administration of 5-androstenediol to mice: Pharmacokinetics and gene expression. Exp Mol Pathol 84 (2008) 178-188
41. Singh V.K., Grace M.B., Parekh V.I., Whitnall M.H., and Landauer M.H. Effects of genistein administration on cytokine induction in whole-body gamma irradiated mice. Int Immunopharmacol 9 (2009) 1401-1410
42. nd ed (1999), Medical Physics Publishing, Madison, WI
43. Riches A.C., Sharp J.G., Thomas D.B., and Smith S.V. Blood volume determination in the mouse. J Physiol 228 (1973) 279-284
44. Reuter S., and Lang D. Life span of monocytes and platelets: importance of interactions. Front Biosci 14 (2009) 2432-2447
45. Saeki Y., Tada K., Sano T., and Takahashi Y. Platelet kinetics after transfusion. Biopharm Drug Dispos 17 (1996) 71-79